Clinical trial
Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus
NCT00425490 · Sheba Medical Center, Other · Completed
Key facts
| NCT number | NCT00425490 |
|---|---|
| Title | Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus |
| Official title | Phase III Study on the Effect of Sitagliptin on Maximal Beta Cell Stimulation |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | sitagliptin |
| Enrollment | 30 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Jan 23, 2007 |
| Last update posted | Sep 23, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: